We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 530

Sun Pharma v Psycoremedies
  • RNA, Intellectual Property Attorneys
  • India
  • October 7 2015

Madras High Court considers impact of twelve years of use and co-existence to set aside the ex parte interim injunction granted on the basis of prior

A review of recent patent opposition cases
  • RNA, Intellectual Property Attorneys
  • India
  • September 24 2015

Opponents in patents opposition cases in the life sciences are now actively relying on grounds of non-patentable invention, under section 3 of the

Pfizer’s Patent Application relating to rheumatoid arthritis drug (Tofacitinib) rejected by Indian patent
  • Khaitan & Co
  • India
  • September 9 2015

The Indian Patent Office (IPO) has passed an order on 3 September 2015 (Order) rejecting patent application no. 991MUMNP2003 (Patent Application

Symed Labs wins process patent protection at Delhi High Court
  • RNA, Intellectual Property Attorneys
  • India
  • July 8 2015

Symed Labs invented a new process for preparation of Linezolid as compared to the earlier existing processes which were tedious and cumbersome. Symed

Compulsory license for AstraZeneca’s diabetes management drug Saxagliptin?
  • Khaitan & Co
  • India
  • July 7 2015

In a recent development, a compulsory license (CL) application has been filed for the patent covering AstraZeneca's diabetes management drug

Phonetic similarity is the key - court holds GENTAC similar to ZANTAC and ZINETAC
  • RNA, Intellectual Property Attorneys
  • India
  • July 2 2015

Glaxo Group Ltd being aggrieved with Systochem Lab’s use of the brand GENTAC for gastro medicines initiated an action against them before the Delhi

Helping the generic market: the Bolar exemption
  • LexOrbis Consulting Pvt Ltd
  • India
  • June 17 2015

A lot of water has flowed under the bridge since the United States enacted the Drug Price Competition and Patent Term Restoration Act 1984, commonly

The battle over sitagliptin between Merck and Glenmark reaches the Supreme Court
  • Lakshmikumaran & Sridharan
  • India
  • May 27 2015

Nearly two years after Merck initiated an infringement action against Glenmark before the Delhi High Court over its Patented diabetics drug

Competition commission conditionally approves Sun-Ranbaxy deal
  • Vaish Associates Advocates
  • India
  • May 14 2015

In a December 5 2014 order the Competition Commission conditionally approved the proposed merger between Sun Pharma and Ranbaxy, subject to the

Generics vs. patented drugs
  • KASS International
  • India, Malaysia
  • April 27 2015

India's incredible advancement in various fields of technology (including launching its own first ever Mars mission!) has attracted other nations to